Page 11 of 33 · 771 questions tagged coa.
This is my second independent submission on material from the same supplier. I can parse the result. I am less sure what it licenses me to conclude. I have…
The particulars: batch certificate · FGP. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to…
Conditions: 98.8% · method section. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics…
What I am working with: retatrutide · two weeks · 25 °C. I am trying to build something sustainable rather than something thorough that I will abandon. I have already…
Setup, so nobody has to ask: FGP · a GLP-1 receptor agonist. This is asserted often enough that I assumed it was established, and then I went looking for the source.…
The method section is present, which is unusual enough that I want to make use of it. These are treated as interchangeable and I do not think they are. If both are…
Concretely: 97.1% · a C4 column · orforglipron. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single…
Details up front: 99.4% · list of related substances. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone…
What I have: JEEP · Flourishglobal Peptide Biotech. I have used one of these for a while and I am considering switching, which requires a reason. What I care about is…
This is my second independent submission on material from the same supplier. I have the document in front of me and I can read the numbers. What I cannot do is…
Conditions: survodutide · four weeks · 40 °C. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I would like…
Concretely: JEEP · a quantified content assay. This should be a straightforward calculation and I keep getting two different answers. The numbers are arbitrary; the…
Details up front: SSA · Hunan Aslsen Technology. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have read the arguments for each…
I have both a purity figure and a content figure, which is why the discrepancy is visible. I want to understand what this actually establishes, as opposed to what it…
What I have: mazdutide · sixteen weeks · minus 20 °C. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me…
The specifics, since they change the answer: 98.8% · PeptideMeter · 98.4%. An unexpected observation, and I would like a differential rather than reassurance. The…
The case in front of me: sampling plan · BCH. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum…
I have been through one internal appeal already and would like to do the next one properly. This is presented as though it settles something, and I am not convinced…
Stated plainly: QYB · Chinese Peptide Company. I am trying to choose between two options that are usually discussed as though only one exists. I am not optimising for…
The pharmacy is accredited and I have verified that on the accreditor register. I would like to know the limits of what can be inferred from this. What I am trying to…
This is my second independent submission on material from the same supplier. Somebody stated this to me confidently and I would like to check it before repeating it.…
Concretely: 96.8% · method section. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics…
Concretely: JEEP · WuXi TIDES. I have used one of these for a while and I am considering switching, which requires a reason. What I care about is reproducibility,…
I have been through one internal appeal already and would like to do the next one properly. The comparison I want does not seem to exist anywhere in a form I can…